Menu Back toWelcoming Remarks and Session 1: Keynote Address - The Coming of Age of Oligonucleotide-Based Therapeutics

DIA/FDA Oligonucleotide-Based Therapeutics Conference

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Welcoming Remarks and Session 1: Keynote Address - The Coming of Age of Oligonucleotide-Based Therapeutics

Session Chair(s)

Ronald Wange, PhD

Ronald Wange, PhD

  • Associate Director for Pharm/Tox, OND, CDER
  • FDA, United States
Scott Henry, PhD

Scott Henry, PhD

  • Vice President, Nonclinical Development
  • Ionis Pharmaceuticals, Inc., United States
In her keynote address, Dr. Woodcock will provide her perspective on the current state of RNA-directed therapeutics, the challenges that still confront the field, and a clear-eyed view of the latent potential that these drugs have to treat a broad array of diseases that currently lack effective treatment options.

Speaker(s)

Janet Woodcock, MD

Speaker

Janet Woodcock, MD

  • Principal Deputy Commissioner
  • FDA, United States

Contact us

Registration Questions?

Send Email
1.888.257.6457

Additional Information

Live Meeting Policies

Discover DIA’s Live In-Person and Live Virtual Events